Halliburton Company reports results for the quarter ended September 30 - Earnings Summary
Halliburton Company reports results for the quarter ended September 30 - Earnings Summary
Halliburton Company HAL.N reported quarterly adjusted earnings of 60 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 58 cents. The mean expectation of twenty five analysts for the quarter was for earnings of 58 cents per share. Wall Street expected results to range from 57 cents to 61 cents per share.
Revenue rose 1.8% to $5.70 billion from a year ago; analysts expected $5.58 billion.
Halliburton Company's reported EPS for the quarter was 50 cents.
The company reported quarterly net income of $417 million.
Halliburton Company shares had risen by 3.7% this quarter and gained 16.7% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 2.4% in the last three months.
In the last 30 days, three analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 22 "strong buy" or "buy," 6 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the oil related services and equipment peer group is also "buy"
Wall Street's median 12-month price target for Halliburton Company is $42.50, about 22.4% above its last closing price of $32.98
This summary was machine generated from LSEG data October 20 at 01:30 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2026 | 0.58 | 0.60 | Beat |
Jun. 30 2026 | 0.54 | 0.55 | Beat |
Mar. 31 2026 | 0.50 | 0.55 | Beat |
Dec. 31 2025 | 0.55 | 0.69 | Beat |
Recent news on Halliburton
See all newsStreet View: Analysts positive on Halliburton after 2027 outlook
US RESEARCH ROUNDUP-Eli Lilly, Netflix, Zscaler
US STOCKS-Dow leads Wall Street higher, investors focus on healthcare stocks
US STOCKS-Wall Street rises with investors rotating into healthcare and value stocks
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly